Maria Kuiper

1.6k total citations
5 papers, 104 citations indexed

About

Maria Kuiper is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Maria Kuiper has authored 5 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Pharmacology. Recurrent topics in Maria Kuiper's work include Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Maria Kuiper is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Maria Kuiper collaborates with scholars based in Netherlands, United States and Germany. Maria Kuiper's co-authors include Cecile Grootscholten, S.H. Goey, James E. Boers, Geerard L. Beets, Robert S. de Jong, Myriam Chalabi, Jos H. Beijnen, Jan H.M. Schellens, Marta López‐Yurda and Maartje Los and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Maria Kuiper

5 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Kuiper Netherlands	3	86	40	38	21	15	5	104
Jane V. Thomas United States	5	87 1.0×	34 0.8×	51 1.3×	48 2.3×	12 0.8×	15	123
Wendong Lei China	4	84 1.0×	47 1.2×	15 0.4×	16 0.8×	17 1.1×	10	126
Yaelle Tuvy United States	4	82 1.0×	48 1.2×	10 0.3×	33 1.6×	10 0.7×	6	108
Yasutaka Takinishi Japan	5	59 0.7×	57 1.4×	17 0.4×	19 0.9×	5 0.3×	14	107
Setareh Samimi Canada	4	72 0.8×	10 0.3×	30 0.8×	17 0.8×	8 0.5×	8	77
Piotr Wandzel Poland	4	49 0.6×	25 0.6×	23 0.6×	59 2.8×	6 0.4×	8	96
Coral Arnau‐Collell Spain	6	65 0.8×	52 1.3×	32 0.8×	16 0.8×	4 0.3×	7	95
Jo Dent United Kingdom	5	149 1.7×	76 1.9×	20 0.5×	49 2.3×	4 0.3×	9	177
E Volpin France	3	100 1.2×	34 0.8×	10 0.3×	40 1.9×	29 1.9×	4	126

Countries citing papers authored by Maria Kuiper

Since Specialization

Citations

This map shows the geographic impact of Maria Kuiper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Kuiper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Kuiper more than expected).

Fields of papers citing papers by Maria Kuiper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Kuiper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Kuiper. The network helps show where Maria Kuiper may publish in the future.

Co-authorship network of co-authors of Maria Kuiper

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Kuiper. A scholar is included among the top collaborators of Maria Kuiper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Kuiper. Maria Kuiper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chalabi, Myriam, Lorenzo F. Fanchi, Geerard L. Beets, et al.. (2018). Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer. Annals of Oncology. 29. viii731–viii731. 46 indexed citations

2.

Chalabi, Myriam, Monique E. van Leerdam, Arend G. J. Aalbers, et al.. (2017). Nivolumab, ipilimumab and COX2-inhibition in early stage colon cancer. Annals of Oncology. 28. v207–v207. 1 indexed citations

3.

Meulendijks, Didier, Jan Willem B. de Groot, Maartje Los, et al.. (2016). Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first‐line treatment of patients with advanced HER2‐negative gastric cancer: A multicenter phase 2 study. Cancer. 122(9). 1434–1443. 28 indexed citations

4.

Meulendijks, Didier, Laurens V. Beerepoot, Henk Boot, et al.. (2015). Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study. Investigational New Drugs. 34(1). 119–128. 28 indexed citations

5.

Helgason, Helgi H., Judith YMN Engwegen, Annemieke Cats, et al.. (2007). Serum proteomic profiling of advanced gastric cancer and identification of proteomic changes following response to epirubicin, cisplatin and capecitabine chemotherapy as diagnostic and predictive biomarkers. Journal of Clinical Oncology. 25(18_suppl). 4537–4537. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact